Aroa Biosurgery (ASX:ARX) Accounts Payable & Accrued Expense : A$3.43 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Aroa Biosurgery Accounts Payable & Accrued Expense?

Aroa Biosurgery's quarterly accounts payable & accrued expense declined from Mar. 2023 (A$3.38 Mil) to Sep. 2023 (A$2.75 Mil) but then increased from Sep. 2023 (A$2.75 Mil) to Mar. 2024 (A$3.43 Mil).

Aroa Biosurgery's annual accounts payable & accrued expense increased from Mar. 2022 (A$2.87 Mil) to Mar. 2023 (A$3.38 Mil) and increased from Mar. 2023 (A$3.38 Mil) to Mar. 2024 (A$3.43 Mil).

Aroa Biosurgery Accounts Payable & Accrued Expense Historical Data

The historical data trend for Aroa Biosurgery's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aroa Biosurgery Accounts Payable & Accrued Expense Chart

Aroa Biosurgery Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Accounts Payable & Accrued Expense

3.80

2.52

2.87

3.38

3.43

Aroa Biosurgery Semi-Annual Data
	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial			2.87	3.39	3.38	2.75	3.43

Aroa Biosurgery Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Aroa Biosurgery (ASX:ARX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aroa Biosurgery Ltd (ASX:ARX) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

64 Richard Pearse Drive, Mangere, Airport Oaks, Auckland, NZL, 2022

Website

https://www.aroabio.com

Aroa Biosurgery Ltd is a soft tissue regeneration company which develops, manufactures and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The Company is in the business of developing, manufacturing and selling soft tissue repair products. The company's principal market is the United States where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery and trauma/limb salvage/tumor surgery.

Aroa Biosurgery (ASX:ARX) Headlines

No Headlines